List of Tables
    Table 1. Renal Diseases Drug Market Opportunities & Trends in Global Market
    Table 2. Renal Diseases Drug Market Drivers in Global Market
    Table 3. Renal Diseases Drug Market Restraints in Global Market
    Table 4. Key Players of Renal Diseases Drug in Global Market
    Table 5. Top Renal Diseases Drug Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Renal Diseases Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Renal Diseases Drug Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Renal Diseases Drug Product Type
    Table 9. List of Global Tier 1 Renal Diseases Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Renal Diseases Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Renal Diseases Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Renal Diseases Drug Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Renal Diseases Drug Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Renal Diseases Drug Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Renal Diseases Drug Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Renal Diseases Drug Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Renal Diseases Drug Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Renal Diseases Drug Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Renal Diseases Drug Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Renal Diseases Drug Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Renal Diseases Drug Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Renal Diseases Drug Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Renal Diseases Drug Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Renal Diseases Drug Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Renal Diseases Drug Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Renal Diseases Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Renal Diseases Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Renal Diseases Drug Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Renal Diseases Drug Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Renal Diseases Drug Product Offerings
    Table 32. Pfizer Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Renal Diseases Drug Product Offerings
    Table 35. Amgen Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 36. Roche Corporate Summary
    Table 37. Roche Renal Diseases Drug Product Offerings
    Table 38. Roche Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 39. GlaxoSmithKline (GSK) Corporate Summary
    Table 40. GlaxoSmithKline (GSK) Renal Diseases Drug Product Offerings
    Table 41. GlaxoSmithKline (GSK) Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 42. Allergan Corporate Summary
    Table 43. Allergan Renal Diseases Drug Product Offerings
    Table 44. Allergan Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 45. AbbVie Corporate Summary
    Table 46. AbbVie Renal Diseases Drug Product Offerings
    Table 47. AbbVie Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 48. Kissei Pharmaceutical Corporate Summary
    Table 49. Kissei Pharmaceutical Renal Diseases Drug Product Offerings
    Table 50. Kissei Pharmaceutical Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca Renal Diseases Drug Product Offerings
    Table 53. AstraZeneca Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 54. FibroGen Corporate Summary
    Table 55. FibroGen Renal Diseases Drug Product Offerings
    Table 56. FibroGen Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 57. Sanofi Corporate Summary
    Table 58. Sanofi Renal Diseases Drug Product Offerings
    Table 59. Sanofi Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 60. Teva Pharmaceutical Industries Corporate Summary
    Table 61. Teva Pharmaceutical Industries Renal Diseases Drug Product Offerings
    Table 62. Teva Pharmaceutical Industries Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 63. Johnson & Johnson Corporate Summary
    Table 64. Johnson & Johnson Renal Diseases Drug Product Offerings
    Table 65. Johnson & Johnson Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
    Table 66. Keryx Biopharmaceuticals Corporate Summary
    Table 67. Keryx Biopharmaceuticals Renal Diseases Drug Product Offerings
    Table 68. Keryx Biopharmaceuticals Renal Diseases Drug Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Renal Diseases Drug Segment by Type in 2021
    Figure 2. Renal Diseases Drug Segment by Application in 2021
    Figure 3. Global Renal Diseases Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Renal Diseases Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Renal Diseases Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Renal Diseases Drug Revenue in 2021
    Figure 8. By Type - Global Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 12. US Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 16. Germany Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 17. France Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 24. China Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. India Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 30. Brazil Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Renal Diseases Drug Revenue Market Share, 2017-2028
    Figure 33. Turkey Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Renal Diseases Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Roche Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. GlaxoSmithKline (GSK) Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Allergan Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AbbVie Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Kissei Pharmaceutical Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. FibroGen Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sanofi Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Teva Pharmaceutical Industries Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Johnson & Johnson Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Keryx Biopharmaceuticals Renal Diseases Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)